Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

被引：0
|
作者：
Schriber, J [1 ]
Christiansen, N [1 ]
Baer, MR [1 ]
Slack, J [1 ]
Wetzler, M [1 ]
Herzig, G [1 ]
机构：
[1] ROSWELL PK CANC INST,DIV MED,BUFFALO,NY 14263
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [1] Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation
    Schriber, J
    Milk, B
    Shaw, D
    Christiansen, N
    Baer, M
    Slack, J
    Tezcan, H
    Wetzler, M
    Herzig, G
    [J]. BONE MARROW TRANSPLANTATION, 1999, 24 (12) : 1311 - 1314
  • [2] Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation
    J Schriber
    B Milk
    D Shaw
    N Christiansen
    M Baer
    J Slack
    H Tezcan
    M Wetzler
    G Herzig
    [J]. Bone Marrow Transplantation, 1999, 24 : 1311 - 1314
  • [3] Veno-occlusive disease (VOD) of the liver following bone marrow transplantation (BMT): Analysis of risk factors and results of therapy with tissue plasminogen activator (tPA).
    Litzow, M
    Repoussis, P
    Schroeder, G
    SchembriWismayer, D
    Batts, K
    Anderson, P
    Arndt, C
    Gastineau, D
    Gertz, M
    Inwards, D
    Lacy, M
    Tefferi, A
    Noel, P
    Solberg, L
    Letendre, L
    Hoagland, H
    [J]. BLOOD, 1997, 90 (10) : 968 - 968
  • [4] Atheroembolic disease following administration of tissue plasminogen activator (TPA)
    Aggarwal, K
    Tjahja, IE
    [J]. CLINICAL CARDIOLOGY, 1996, 19 (11) : 906 - 908
  • [5] INTRACAMERAL TISSUE-PLASMINOGEN ACTIVATOR (TPA) FOLLOWING GLAUCOMA SURGERY
    LUNDY, DC
    SIDOTI, P
    WINARKO, T
    LEE, PP
    MINCKLER, DS
    HEUER, DK
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S21 - S21
  • [6] Eligibility for hyperacute thrombolytic therapy with tissue plasminogen activator (tPA) in children
    Rafay, M. F.
    Pontigon, A.
    Chiang, J.
    Jarvis, A.
    Silver, F.
    MacGregor, D.
    deVeber, G.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S142 - S143
  • [7] SAFETY AND EFFICACY OF HEPARIN-PROPHYLAXIS AND TISSUE-PLASMINOGEN ACTIVATOR (TPA) TREATMENT FOR VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION (BMT)
    ROSENTHAL, J
    SENDER, L
    MONTES, V
    WEINTHAL, J
    SUAREZ, M
    LORANGER, N
    SECOLA, R
    KILLEN, R
    GOWAN, D
    FLORENCE, K
    MEIMAN, S
    CAIRO, MS
    [J]. BLOOD, 1993, 82 (10) : A410 - A410
  • [8] VERY EARLY THERAPY FOR CEREBRAL INFARCTION WITH TISSUE PLASMINOGEN-ACTIVATOR (TPA)
    BROTT, T
    HALEY, EC
    LEVY, DE
    BARSAN, WG
    REED, RL
    OLINGER, CP
    MARLER, JR
    [J]. STROKE, 1988, 19 (01) : 133 - 133
  • [9] TISSUE PLASMINOGEN-ACTIVATOR (TPA) AS VERY EARLY THERAPY FOR CEREBRAL INFARCTION
    BROTT, TG
    HALEY, EC
    LEVY, DE
    BARSAN, WG
    REED, RL
    ARMITAGE, JL
    MARLER, JR
    [J]. CIRCULATION, 1987, 76 (04) : 142 - 142
  • [10] The vasoactivity of tissue type plasminogen activator (tPA) and TNK-tPA
    Nassar, H
    Nassar, T
    Haj-Yehia, A
    Akkawi, S
    Bdeir, K
    Higazi, AR
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 250 - 250
12345